Identification of Risk Factors for Elevated Transaminases in Methotrexate Users Through an Electronic Health Record
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Objective: To determine the predictors of elevated transaminases in an incident user cohort of older adult patients with rheumatic diseases receiving methotrexate (MTX) using elements derived from an electronic health record. Methods: Using a national, administrative database of patients seen through the Veterans Health Administration that included pharmacy and laboratory data, we performed an observational cohort study of veterans ages ≥65 years who were new users of MTX to identify risk factors for elevated transaminases. Results: We studied 659 incident users of MTX. We found a 6% incidence of moderate (≥1.5 × the upper limit of normal) elevations in aspartate aminotransferase or alanine aminotransferase over a mean followup period of 7 months. We identified predictors of moderate transaminase elevations to include obesity (per body mass index ≥30 kg/m 2), total cholesterol >240 mg/dl, pre‐MTX liver function test (LFT) elevations, use of biologic agents, and lack of folic acid supplementation. A patient with these characteristics and >3 comorbid conditions would be predicted to have a 90% chance of developing a moderate transaminase elevation in the 7 months after starting MTX. Conclusion: Moderate LFT abnormalities were uncommon in the first 7 months of MTX use, but were more likely to occur in patients with obesity, untreated high cholesterol, pre‐MTX LFT elevations, biologic agent use, and lack of folic acid supplementation. Future work should aim to develop a robust, automated prediction rule for identifying patients at high risk for MTX‐related liver toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Established risk factors for accelerated liver injury with methotrexate therapy include active alcohol consumption, pre‐existing liver disease, diabetes, hyperlipidemia, and obesity.191”
From AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury (2023) · cites this paper as [191]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Abnormal hepatic biochemistries in patients with inflammatory bowel disease
Mendes, F. D., Levy, C., Enders, F. B., Loftus, E. V., Angulo, P., & Lindor, K. D. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00947.x · Cited by 147
Nol, P. H., Copeland, L. A., Perrin, R. A., Lancaster, A. E., Pugh, M. J., Wang, C.-P., Bollinger, M. J., & Hazuda, H. P. (2010) · The Journal of Rehabilitation Research and Development · doi:10.1682/jrrd.2009.08.0110 · Cited by 77
Research works printed but not linked: 27
- Sokka T, 2010, Increases in use of methotrexate since the 1980s, Clin Exp Rheumatol, 28, S13
- Davis SA, 2013, Combination therapy for psoriasis in the United States, J Drugs Dermatol, 12, 546
- Visser K, 2009, Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature, Clin Exp Rheumatol, 27, 1017
- 10.1002/art.23721 · DOI · Paper page
- Kent PD, 2004, Risk factors for methotrexate‐induced abnormal laboratory monitoring results in patients with rheumatoid arthritis, J Rheumatol, 31, 1727
- 10.1136/ard.2009.112136 · DOI
- 10.1002/art.30155 · DOI · Paper page
- 10.1111/j.1532-5415.2012.04158.x · DOI · Paper page
- 10.1186/1472-6963-7-54 · DOI
- 10.1097/00005650-199306000-00003 · DOI · Paper page
- 10.1177/106286060401900504 · DOI · Paper page
- 10.1016/0895-4356(92)90133-8 · DOI · Paper page
- 10.1056/NEJMra052270 · DOI · Paper page
- Harrell FE, 1996, Tutorial in biostatistics, Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med, 15, 361
- Kremer JM, 1996, Significant changes in serum AST across hepatic histological biopsy grades: prospective analysis of 3 cohorts receiving methotrexate therapy for rheumatoid arthritis, J Rheumatol, 23, 459
- 10.1097/MLR.0b013e3181ef60d9 · DOI · Paper page
- 10.1111/j.1475-6773.2010.01126.x · DOI · Paper page
- 10.1002/1529-0131(200107)44:7<1515::AID-ART273>3.0.CO;2-7 · DOI · Paper page
- 10.1371/journal.pone.0004435 · DOI
- 10.1002/hep.23784 · DOI · Paper page
- 10.1002/anr.1780320202 · DOI · Paper page
- 10.1016/j.jhep.2006.05.008 · DOI
- 10.1002/acr.20629 · DOI · Paper page
- 10.1136/ard.62.9.842 · DOI · Paper page
- 10.1002/pds.1454 · DOI
- 10.1097/MD.0b013e318211106a · DOI · Paper page
- 10.1136/ard.49.8.591 · doi:10.1136/ard.49.8.591
Cited by
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Fontana, R. J., Liou, I., Reuben, A., Suzuki, A., Fiel, M. I., Lee, W., & Navarro, V. (2023) · Hepatology · doi:10.1002/hep.32689 · Cited by 340
Risk of liver disease in methotrexate treated patients
Conway, R., & Carey, J. J. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i26.1092 · Cited by 170
Bessone, F., Dirchwolf, M., Rodil, M. A., Razori, M. V., & Roma, M. G. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14952 · Cited by 102
Takeuchi, T., Yamanaka, H., Harigai, M., Tamamura, R., Kato, Y., Ukyo, Y., Nakano, T., Hsu, B., & Tanaka, Y. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1536-9 · Cited by 18
Metadata
- Authors
- Schmajuk, G., Miao, Y., Yazdany, J., Boscardin, W. J., Daikh, D. I., & Steinman, M. A.
- Affiliations
- Veterans Affairs Medical Center and University of California San Francisco
- Veterans Affairs Medical Center San Francisco California
- University of California San Francisco
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2014-07-28
- Volume
- 66
- Issue
- 8
- Pages
- 1159-1166
- ISSN
- 2151-464X
- 2151-4658
- Cited by
- 69
- References
- 2
- Language
- en
- Funders
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR060259, AR063770)
- National Institute on Aging (AG030999, AG036377)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Identification of Risk Factors for Elevated Transaminases in Methotrexate Users Through an Electronic Health Record. https://app.cochat.ai/papers/10.1002/acr.22294
- The paper
- Schmajuk, G., Miao, Y., Yazdany, J., Boscardin, W. J., Daikh, D. I., & Steinman, M. A. (2014). Identification of Risk Factors for Elevated Transaminases in Methotrexate Users Through an Electronic Health Record. Arthritis Care & Research. https://doi.org/10.1002/acr.22294
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.